Reducing greenhouse gas emissions is a major challenge. Inhalers have a significant impact on the environment due to their greenhouse gas emissions. However, inhalation therapy plays a fundamental and essential role in the treatment of patients with cystic fibrosis. They therefore represent a target group with high potential for the implementation of strategic measures to reduce the environmental impact of devices.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Hand eczema: from diagnosis to treatment
Implementing sustainable, stage-appropriate measures
- Cystic fibrosis
Small spray – big footprint
- From symptom to diagnosis
Abdominal pain – Gastric outlet stenosis
- When the bones become more fragile: “Case Finding”
Fracture risk reduction in osteoporosis
- Biologics for plaque psoriasis
What increases the chance of a sustained remission?
- Pain and autism
Hurdles to pain treatment for autistic patients
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Long-COVID